Cannabis in 2019
So far, 2019 looks like it’s going to be a big year for cannabis stocks. The world is getting an opportunity to witness the cannabis industry’s real potential through cannabis stocks. To learn more, read Cannabis 2019: Comparing Jim Cramer’s Views with Market Realist’s.
With just two more trading days remaining, let’s look at how some of the major cannabis stocks have fared in January.
In the above chart, you can see that all of the cannabis stocks presented gained in January. The Horizons Marijuana Life Sciences ETF (HMMJ) gained nearly 38%, while the TSE 300 Index gained ~7.4%. Cannabis investors are relatively wealthier compared to the market in January.
Canopy Growth (WEED) (CGC) has been the biggest gainer with an 89% gain in January. Jim Cramer said that Canopy Growth stock is the best. The stock is a top investment choice for cannabis enthusiasts that want to invest safely. Cronos Group (CRON), which Jim Cramer said is the second-best cannabis stock, has gained nearly 77.9% YTD (year-to-date) as of January 29.
HEXO (HEXO) was third on the list with a 48% return followed by Supreme Cannabis (SPRWF), which has gained nearly 47.7% YTD. OrganiGram (OGRMF), which reported its earnings on January 28, was fifth with returns of 46.5%. To learn more, read OrganiGram Rose 18% after Its First-Quarter Earnings. CannTrust (CNTTF) was sixth with a gain of ~43.5%.
Aurora Cannabis (ACB) has gained 39%, Aphria (APHA) has gained ~24.7%, and Tilray (TLRY) has gained ~16%.